Approaches to Personalized Treatment for CLL: Expert Guidance on Sequencing Therapy and Novel Agents

In this satellite symposium, experts discuss the optimal management strategy for patients with CLL, including evidence-based best practices and practical application of the NCCN Guidelines. Download the slides from this dynamic satellite symposium and a clinician resource to learn more about current treatment algorithm and ongoing clinical trials in CLL.
William G. Wierda, MD, PhD

Clinician Resource

Download this clinician resource to review the current treatment algorithm and key clinical trials in CLL.

William G. Wierda, MD, PhD Released: December 5, 2019
Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC
NCCN Logo

Karen Kanefield
Manager CE Accreditation & Program Operations
National Comprehensive Cancer Network
3025 Chemical Road, Suite 100
Plymouth Meeting, PA 19462

215-690-0239
215-690-0283 (Fax)
gianola@nccn.org
For Clinicians:
NCCN.org
For Patients:
NCCN.org/patients

Supported by educational grants from
AstraZeneca
BeiGene, Ltd.
Pharmacyclics LLC, an AbbVie Company
Janssen Biotech, Inc., administered by Pharmacyclics, LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue